PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING N-1H-BENZIMIDAZOL-2-YL-3-(1H-PYRROLE-1-YL)BENZAMIDE AS ACTIVE INGREDIENT

    公开(公告)号:US20210379022A1

    公开(公告)日:2021-12-09

    申请号:US17285464

    申请日:2019-09-03

    摘要: The present invention relates to a pharmaceutical composition for preventing or treating cancer, a radiosensitizer composition for treating cancer, and a health functional food for preventing or improving cancer, which comprise N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide, a derivative thereof, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition comprising N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide or a derivative thereof as an active ingredient according to the present invention arrests the mitosis of cancer cells to prevent proliferation and at the same time, to exhibit low toxicity in normal cell lines and induce apoptosis only in cancer cell lines, so it can be used as an effective anticancer agent. In addition, the N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide of the present invention can increase the sensitivity of the treated cancer cells to radiation, so it can be used as a radiosensitizer composition for cancer treatment.